Title:
【発明の名称】アンチセンスオリゴヌクレオチドおよびヒト免疫不全ウイルス感染におけるその使用
Document Type and Number:
Japanese Patent JP2798305
Kind Code:
B2
Abstract:
The present invention is directed to oligonuclegtides comprising nucleotide sequences sufficiently complementary to conserved regions of human immunodeficiency virus genetic material such that when bound to said region, the oligonucleotides effectively prevent expression of the genetic material.
Inventors:
Friesen, Albert Di.
Application Number:
JP50262795A
Publication Date:
September 17, 1998
Filing Date:
June 23, 1994
Export Citation:
Assignee:
Genesis Pharma Inc.
International Classes:
C12N15/09; A61K31/70; A61K31/7088; A61K47/14; A61K48/00; A61P31/12; C07H21/04; C12N15/113; C12N15/85; C12Q1/68; (IPC1-7): C12N15/09; A61K31/70; A61K47/14; A61K48/00
Domestic Patent References:
| JP2276577A | ||||
| JP4501052A |
Other References:
【文献】国際公開91/18004(WO,A1)
【文献】国際公開92/2531(WO,A1)
【文献】国際公開92/2531(WO,A1)
Attorney, Agent or Firm:
Shusaku Yamamoto